Citations

Showing 10 of 108104 citations.

Prone Whole-Breast Radiotherapy—Better Than Supine?
Shumway, Dean A. , Atkins, Katelyn M.

Mayo Clinic

JAMA Oncology | May 26, 2022 | Volume: 8 | Issue: 7 | Pages: 983

10.1001/jamaoncol.2022.1384 | PMID 35616925 Get It

Ebstein Anomaly—Of Veils and Visions
Stephens, Elizabeth H. , Dearani, Joseph A.

Mayo Clinic

JAMA | May 26, 2022 | Volume: 327 | Issue: 22 | Pages: 2173

10.1001/jama.2022.7679 | PMID 35616918 Get It

What do we know about Toll-Like Receptors Involvement in Gout Arthritis?
Silva, Cássia Regina , Saraiva, André Lopes , Rossato, Mateus Fortes, Rossato, Mateus Fortes , Trevisan, Gabriela , Oliveira, Sara Marchesan

Mayo Clinic

Endocrine, Metabolic & Immune Disorders - Drug Targets | May 26, 2022 | Volume: 23 | Issue: 4 | Pages: 446-457

10.2174/1871530322666220523145728 | PMID 35616672 Get It

Abstract:Toll-like receptors (TLRs) are a well-characterized family of cell-bound pattern recognition receptors able to identify and respond to conserved structures of external microorganisms or Pathogen Molecular-Associated Pattern (PAMPs). They can also interact with Damage-Associated Molecular Patterns (DAMPs) involved with any infectious and sterile cell stress of tissue injury. Accumulated knowledge about TLRs has revealed that these receptors and intracellular signaling pathways triggered through TLR activation contribute to the physiopathology of different inflammatory diseases, including arthritic conditions. Mostly, the literature focuses on exploring TLRs in rheumatoid and osteoarthritis. However, TLRs also seem to be an essential mediator for monosodium urate (MSU) crystals-induced gouty arthritis, both in animal models and humans. Accordingly, naked MSU crystals have a highly negatively charged surface recognized by TLRs; intracellular adapter protein MyD88 are significant mediators of MSU crystals-induced IL1β production in mice, and gouty patients demonstrate a robust positive correlation between TLR4 mRNA level and serum IL1β. Here, we revised the literature evidence regarding the involvement of TLRs in gout arthritis pathogenesis, with particular reference to TLR2 and TLR4, by analyzing the actual literature data.
A stress-induced cilium-to-PML-NB route drives senescence initiation
Hu, Jinghua , Ma, Xiaoyu , Zhang, Yingyi , Zhao, Debiao , Kirkland, James L. , Chini, Eduardo N. , Ling, Kun , Zhang, Yingyi , Zhang, Yuanyuan , Zhang, Xu , Huang, Yan , He, Kai , Chen, Chuan , Hao, Jielu , LeBrasseur, Nathan K. , Wei, Qing

Mayo Clinic

No container title available | May 26, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1522828/v1 Get It

Abstract Cellular senescence contributes to tissue homeostasis and age-related pathologies. However, how senescence is initiated in damaged cells remains vague. Here, we discover that irreparable stresses induce transient biogenesis of cilia, which are used by stressed cells to directly communicate with the promyelocytic leukemia nuclear bodies (PML-NBs), the validated stress signaling hub, to initiate senescence responses. Mechanistically, a ciliary ARL13B-ARL3 GTPase cascade negatively regulates the association of transition fiber protein FBF1 and SUMO-conjugating enzyme UBC9. Irreparable stresses downregulate the ciliary ARLs to release UBC9, which SUMOylates FBF1 at the ciliary base. SUMOylated FBF1 then translocates to PML-NBs to promote PML-NB-dependent senescence initiation. Remarkably, Fbf1 suppression effectively subdues global senescence burden and prevents associated health-span decline in irradiation-treated mice. Collectively, our findings assign primary cilia a central role in inducing senescence program and identify them as promising targets to dampen senescence-associated detrimental damage in future senotherapy strategies.
Intraneural ganglion cysts at the hip: The next celestial frontier
Spinner, Robert J. , Desy, Nicholas M. , Amrami, Kimberly K.

Mayo Clinic

Muscle & Nerve | May 26, 2022 | Volume: 66 | Issue: 3 | Pages: 236-239

10.1002/mus.27643 | PMID 35616442 Get It

See article on pages 339‐344 in this issue
Cytokeratin-Derived Amyloid Mimicking Invasive Squamous Cell Carcinoma: Overcoming a Potential Pitfall of Pan-Cytokeratin Immunohistochemistry–Assisted Mohs Micrographic Surgery
Idriss, Munir H., Ahn, Ji Won, Johnson, Emma F. , Vidal, Nahid Y. , Demer, Addison M.

Mayo Clinic

Dermatologic Surgery | May 26, 2022 | Volume: 48 | Issue: 8 | Pages: 887-889

10.1097/dss.0000000000003493 | PMID 35617106 Get It

Gene Expression Profiles of Treatment Response and Non‐Response in Children With Juvenile Dermatomyositis
Stingl, Cory , Dvergsten, Jeffrey , Eng, Simon , Mason, Thomas G. , Crowson, Cynthia S. , Reed, Ann M. , Mason, Thomas, Crowson, CS , Reed, Ann M , Eng, Simon W M , Yeung, Rae S. M. , Fritzler, Marvin J. , Mason, Thomas, Voora, Deepak

Mayo Clinic

ACR Open Rheumatology | May 26, 2022 | Volume: 4 | Issue: 8 | Pages: 671-681

10.1002/acr2.11445 | PMID 35616642 Get It

ObjectiveThe study objective was to identify differences in gene expression between treatment responders (TRs) and treatment non‐responders (TNRs) diagnosed with juvenile dermatomyositis (JDM).MethodsGene expression analyses were performed using whole blood messenger RNA sequencing in patients with JDM (n = 17) and healthy controls (HCs; n = 10). Four analyses were performed (A1‐4) comparing differential gene expression and pathways analysis exploiting the timing of sample acquisition and the treatments received to perform these comparative analyses. Analyses were done at diagnosis and follow‐up, which averaged 7 months later in the cohort.ResultsAt diagnosis, the expression of 10 genes differed between TRs and TNRs. Hallmark and canonical pathway analysis revealed 11 and 60 pathways enriched in TRs and 3 and 21 pathways enriched in TNRs, respectively. Pathway enrichment at diagnosis in TRs was strongest in pathways involved in metabolism, complement activation, and cell signaling as mediated by IL‐8, p38/microtubule associated protein kinases (MAPK)/extracellular signal‐regulated kinases (ERK), Phosphatidylinositol 3 Kinase Gamma (PI3Kγ), and the B cell receptor. Follow‐up hallmark and canonical pathway analysis showed that 2 and 14 pathways were enriched in TRs, whereas 24 and 123 pathways were enriched in treatment TNRs, respectively. Prior treatment with glucocorticoids significantly altered expression of 13 genes in the analysis of subjects at diagnosis with JDM as compared with HCs.ConclusionNumerous genes and pathways differ between TRs and TNRs at diagnosis and follow‐up. Prior treatment with glucocorticoids prior to specimen acquisition had a small effect on the performed analyses.
Enhancement of Impaired MRSA-Infected Fracture Healing by Combinatorial Antibiotics and Modulation of Sustained Inflammation
Yu, Kristin E. , Kwon, Hyuk‐Kwon , Dussik, Christopher M. , Cahill, Sean V. , Back, Jungho , Alder, Kareme D. , Lee, Francis Y. , Lee, Francis Y

Mayo Clinic

Journal of Bone and Mineral Research | May 26, 2022 | Volume: 37 | Issue: 7 | Pages: 1352-1365

10.1002/jbmr.4570 | PMID 35616626 Get It

ABSTRACT Fracture healing is impaired in the setting of infection, which begets protracted inflammation. The most problematic causative agent of musculoskeletal infection is methicillin-resistant Staphylococcus aureus (MRSA). We hypothesized that modulation of excessive inflammation combined with cell-penetrating antibiotic treatments facilitates fracture healing in a murine MRSA-infected femoral fracture model. Sterile and MRSA-contaminated open transverse femoral osteotomies were induced in 10-week-old male C57BL/6 mice and fixed via intramedullary nailing. In the initial therapeutic cohort, empty, vancomycin (V), rifampin (R), vancomycin-rifampin (VR), or vancomycin-rifampin-trametinib (VRT) hydrogels were applied to the fracture site intraoperatively. Rifampin was included because of its ability to penetrate eukaryotic cells to target intracellular bacteria. Unbiased screening demonstrated ERK activation was upregulated in the setting of MRSA infection. As such, the FDA-approved mitogen-activated protein kinase kinase (MEK)1-pERK1/2 inhibitor trametinib was evaluated as an adjunctive therapeutic agent to selectively mitigate excessive inflammation after infected fracture. Two additional cohorts were created mimicking immediate and delayed postoperative antibiotic administration. Systemic vancomycin or VR was administered for 2 weeks, followed by 2 weeks of VRT hydrogel or oral trametinib therapy. Hematologic, histological, and cytokine analyses were performed using serum and tissue isolates obtained at distinct postoperative intervals. Radiography and micro-computed tomography (μCT) were employed to assess fracture healing. Pro-inflammatory cytokine levels remained elevated in MRSA-infected mice with antibiotic treatment alone, but increasingly normalized with trametinib therapy. Impaired callus formation and malunion were consistently observed in the MRSA-infected groups and was partially salvaged with systemic antibiotic treatment alone. Mice that received VR alongside adjuvant MEK1-pERK1/2 inhibition displayed the greatest restoration of bone and osseous union. A combinatorial approach involving adjuvant cell-penetrating antibiotic treatments alongside mitigation of excessive inflammation enhanced healing of infected fractures. © 2022 American Society for Bone and Mineral Research (ASBMR).
Modifications to Implanting the OSIA® 2 Bone Conduction Hearing Implant: How I Do it
Deep, Nicholas L. , Johnson, Brian J. , Kay‐Rivest, Emily , Carlson, Matthew L. , Driscoll, Colin L. W., Friedmann, David R , Johnson, Brian Jake , Roland, J. Thomas , Jethanamest, Daniel

Mayo Clinic

The Laryngoscope | May 26, 2022 | Volume: 132 | Issue: 9 | Pages: 1850-1854

10.1002/lary.30153 | PMID 35616210 Get It

Computed tomography measured tissue density of pectoral muscle and liver predicts outcomes in heart transplant recipients
Kuchnia, Adam J. , Lortie, Jevin , Osterbauer, Katie, Hess, Timothy , Stabo, Nicholas, Wheeler, Nathan , Binkley, Neil , Hermsen, Joshua L., Dhingra, Ravi , Tsuchiya, Nanae , François, Christopher J. , Schiebler, Mark

Mayo Clinic

JCSM Rapid Communications | May 26, 2022 | Volume: 5 | Issue: 2 | Pages: 171-181

10.1002/rco2.62 Get It

AbstractBackgroundComputed tomography (CT)‐derived measures of tissue quality can add to frailty assessment and improve selection of candidates for heart transplant. We investigated the prognostic value of CT measures of tissue density for predicting hospital length of stay (LOS) and mortality post‐transplant.MethodsAll patients at a quaternary care hospital between 1999 to 2018 with preheart transplant CT scans and available data on transplant outcomes were eligible (n = 189), including a subset within the total cohort with scans 6‐month pretransplant (n = 103). Axial chest CT scans were analysed for liver and muscle density at the 12th thoracic vertebrae and aortic arch landmarks, respectively. Cox and linear regression models examined the risk of death and LOS, respectively, according to median (above or below) pectoral muscle density. Low‐density muscle (LDM) area and liver density were analysed as continuous variables.ResultsOut of 157 patients with readable CT scans (median age 55 years, interquartile range [50–60] 10% women), 31 died on 1‐year follow up. Patients with higher than and at median pectoral muscle density (39.5 Hounsfield Unit [HU]) had better 1‐year survival in the overall cohort (hazard ratio [HR] 0.82, 95% confidence interval [CI] 0.673, 0.989; p = 0.039), with the 6‐month cohort showing a trend (HR 0.79, 95% CI 0.603, 1.023; p = 0.074) towards improved survival. Conversely, every 5‐cm2 increase in pectoral LDM area was associated with 2.4‐day lower LOS (p = 0.045) in the overall cohort, and a 2.6‐day lower LOS in the 6‐month cohort (p = 0.05). Patients with higher ratio of normal‐density muscle to LDM had higher LOS (p < 0.01). Every 5‐HU increase in liver density at a region of interest was associated with 0.24‐day higher post‐transplant LOS in the overall cohort, and a 0.41 higher LOS in the 6‐month cohort (p ≤ 0.05).ConclusionsPatients with higher preheart transplant pectoral muscle density had greater 1‐year survival. Higher pectoral LDM area was associated with decreased LOS post‐transplant and higher liver density was associated with increased LOS. These findings raise possibilities that measures of muscle density as they reflect to quality of muscle may have prognostic implications. Future studies with prospective design are needed to confirm these findings.